Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia.

about

The Influence of Androgen Deprivation Therapy on Prostate Size and Voiding Symptoms in Prostate Cancer Patients in Korea.

P2860

Q37554004-9412B206-EB8C-4CF4-8C76-425736967A91

P2860

Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia.

Item

http://www.wikidata.org/entity/Q39015782

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Effect of 5-alpha Reductase In ...... Benign Prostatic Hyperplasia.

@en

Effect of 5-alpha Reductase In ...... Benign Prostatic Hyperplasia.

@nl

type

Item

label

Effect of 5-alpha Reductase In ...... Benign Prostatic Hyperplasia.

@en

Effect of 5-alpha Reductase In ...... Benign Prostatic Hyperplasia.

@nl

prefLabel

Effect of 5-alpha Reductase In ...... Benign Prostatic Hyperplasia.

@en

Effect of 5-alpha Reductase In ...... Benign Prostatic Hyperplasia.

@nl

P1476

Effect of 5-alpha Reductase In ...... Benign Prostatic Hyperplasia.

@en

P2093

Hyo Sin Kim

http://www.w3.org/2001/XMLSchema#string

Joon Chul Kim

http://www.w3.org/2001/XMLSchema#string

Jun Sung Koh

http://www.w3.org/2001/XMLSchema#string

Kang Jun Cho

http://www.w3.org/2001/XMLSchema#string

Se Hee Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations

Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia.

The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (Com

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations.

Efficacy and safety of low-dose propiverine in patients with lower urinary tract symptoms/benign prostatic hyperplasia with storage symptoms: a prospective, randomized, single-blinded and multicenter clinical trial.

Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life.

Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician.

EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

The detrusor muscle: an innocent victim of bladder outlet obstruction.

A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.

P304

152-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5213/INJ.2011.15.3.152

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51800615

http://www.w3.org/2001/XMLSchema#string

P698

22087424

http://www.w3.org/2001/XMLSchema#string

P932

3212589

http://www.w3.org/2001/XMLSchema#string

Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia.

about

P2860

P2860

Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932